GS
72
2
AFL
39
2
LB
35
3
AIZ
40
-16
SLG
48
2
UAL
31
2
SWK
39
2
PNW
52
-3
HSY
32
-3
ES
40
-2
D
48
2
CCL
64
3
EXR
46
-2
URBN
56
-12
UNP
36
3
RCL
79
3
PSA
38
-2
NKE
25
2
LYB
11
-2
CVX
32
3
GS
72
2
AFL
39
2
LB
35
3
AIZ
40
-16
SLG
48
2
UAL
31
2
SWK
39
2
PNW
52
-3
HSY
32
-3
ES
40
-2
D
48
2
CCL
64
3
EXR
46
-2
URBN
56
-12
UNP
36
3
RCL
79
3
PSA
38
-2
NKE
25
2
LYB
11
-2
CVX
32
3
Financhill
Back

The Descartes Systems Group Vs. Blueprint Medicines Industry Stock Comparison

Sell
36

DSGX
The Descartes Systems Group

Last Price:
$99.01
Seasonality Move:
3.45%
Buy
52

BPMC
Blueprint Medicines

Last Price:
$128.13
Seasonality Move:
11.22%
Sell
36
The Descartes Systems Group (DSGX) is a Sell

Is The Descartes Systems Group a Buy, Sell or Hold?

  • The current The Descartes Systems Group [DSGX] share price is $98.97. The Score for DSGX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • DSGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Blueprint Medicines (BPMC) is a Buy

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $128.12. The Score for BPMC is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DSGX Stock Price Chart

What is The Descartes Systems Group's stock price today?

  • The The Descartes Systems Group share price today is $98.97
    The current trend is moderately bearish and DSGX is experiencing buying pressure, which is a positive indicator for future bullish movement.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $128.12
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight selling pressure.

DSGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.29 Sell
Relative Strength Index (14 RSI): 35.16 Sell
Chaikin Money Flow: 218259 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (101.32 - 115.66) Sell
Bollinger Bands (100): (100.54 - 114.88) Sell

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.03 Buy
Relative Strength Index (14 RSI): 75.53 Buy
Chaikin Money Flow: -1180116 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.99 - 128.61) Buy
Bollinger Bands (100): (85.1 - 113.52) Buy

DSGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 99.34 Sell
20-day SMA: 107.36 Sell
50-day SMA: 106.65 Sell
200-day SMA: 108.43 Sell
8-day EMA: 100.47 Sell
20-day EMA: 104.26 Sell
50-day EMA: 97.63 Buy
200-day EMA: 49.48 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 128.08 Buy
20-day SMA: 118.35 Buy
50-day SMA: 102.34 Buy
200-day SMA: 95.74 Buy
8-day EMA: 127.05 Buy
20-day EMA: 120.04 Buy
50-day EMA: 108.59 Buy
200-day EMA: 97.88 Buy

The Descartes Systems Group Earnings Growth & DSGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.03 per share, an increase this year of $0.62 per share, and an increase next year of $0.23 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.

The Descartes Systems Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):